| Ytd | -13.58% | |
| 1y | -11.07% |
| Open | 20.60 | Prev Close | 20.79 | Low | 20.34 | High | 20.77 | Mkt Cap | 2.62B |
| Vol | 922.12K | Avg Vol | 1.19M | EPS | 0.22 | P/E | 93.14 | Forward P/E | 19.27 |
| Beta | 0.90 | Short Ratio | 3.98 | Inst. Own | 98.30% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 24.26 | 200-d Avg | 23.32 | 1yr Est | 31.67 |
PRVA News
Bank of New York Mellon Corp acquired a new stake in Privia Health Group, Inc. (NASDAQ: PRVA) in the
Deutsche Bank AG purchased a new stake in shares of Privia Health Group, Inc. (NASDAQ: PRVA) in the
BlackRock Inc. acquired a new stake in shares of Privia Health Group, Inc. (NASDAQ: PRVA) in the sec
ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced
Privia Health Group NASDAQ: PRVA reported second-quarter results marked by double-digit growth in im
On August 06, 2026, Privia Health Group Inc (PRVA) shares fell 8.2% today, bringing the current pric
Privia Health Group, Inc. (PRVA) Q2 2026 Earnings Call Transcript
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.19 per share which beat the analyst
Privia Health (PRVA) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensu
Privia Health Gr (NASDAQ:PRVA) affirms FY2026 sales outlook from $2.350 billion-$2.450 billion to $2
2Q'26 Net Income of $9.0M, +236.7% from 2Q'25 2Q'26 Adjusted EBITDA of $37.4M, +29.1% from 2Q'25 Ful
Dimensional Fund Advisors LP grew its stake in Privia Health Group, Inc. (NASDAQ: PRVA) by 6.3% duri
On July 22, 2026, Privia Health Group Inc (PRVA) shares fell 3.6% today, bringing the current price
Warning: RSI is above 70 for 3 overbought stocks in healthcare. Progyny, 10X Genomics, and Privia He
Former CEO Shawn Morris sold 135,498 shares on June 30 and July 1, 2026, generating proceeds of ~$3.
ARLINGTON, Va., July 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today ann
CEO Parth Mehrotra sold 121,086 shares directly for a total of ~$2.73 million at an average price of
On June 04, 2026, Privia Health Group Inc (PRVA) shares rose 3.4% to a current price of $21.37. Over
Privia Health Group delivers technology-driven solutions to optimize physician practices and support
Fort Lauderdale, May 28, 2026 (GLOBE NEWSWIRE) -- Cross Keys Capital, LLC, a leading independent inv
Investors looking for stocks in the Medical Info Systems sector might want to consider either TruBri
ARLINGTON, Va., May 27, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), a nationa
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and l
Privia Health Gr (NASDAQ:PRVA) affirms FY2026 sales outlook from $2.350 billion-$2.450 billion to $2
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.19 per share which beat the analyst
Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Out
Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and rais
Citigroup analyst Daniel Grosslight maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lower
Amalgam Rx, Inc., a leader in data-driven, AI-powered healthcare engagement and clinical decision su
Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and r
Privia Health Gr (NASDAQ:PRVA) sees FY2026 sales of $2.350 billion-$2.450 billion vs $2.380 billion
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.25 per share which beat the analyst
Renaissance Group made massive moves in Netflix, Lam Research and ServiceNow, signaling rising hedge
Stephens & Co. analyst Jeff Garro reiterates Privia Health Gr (NASDAQ:PRVA) with a Overweight
JP Morgan analyst Lisa Gill maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and raises
BMO Capital analyst Sean Dodge initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Outper
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and r
Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and rais
Truist Securities analyst Jailendra Singh reiterates Privia Health Gr (NASDAQ:PRVA) with a Buy an
Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Out
Citizens analyst Constantine Davides maintains Privia Health Gr (NASDAQ:PRVA) with a Market Outpe
Privia Health Gr (NASDAQ:PRVA) raises FY2025 sales outlook from $1.800 billion-$1.900 billion to $2.
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.29 per share which beat the analyst
Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and rais